Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Remeditex Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 17
Average round size
info
The average size of a deal this fund participated in
$24M
Portfolio companies 10
Rounds per year 1.31
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 7
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Therapeutics
  • Biotechnology
  • Pharmaceutical
  • Medical Device
Summary

The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Remeditex Ventures, startups are often financed by Boulder Ventures, Amgen Ventures, Broadview Ventures. The meaningful sponsors for the fund in investment in the same round are Atlas Venture, Boulder Ventures, Amgen Ventures. In the next rounds fund is usually obtained by Boulder Ventures, Atlas Venture, Amgen Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Biopharma. The fund has exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Rodin Therapeutics, Bi02 Medical, Navitor Pharmaceuticals

The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. This Remeditex Ventures works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2019. The typical startup value when the investment from Remeditex Ventures is 100-500 millions dollars. The real fund results show that this VC is 8 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Remeditex Ventures:
Typical Co-investors
Remeditex Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Remeditex Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bihoop Ventures Barcelona, Catalonia, Spain
Block Dream Fund -
Defense.Net Belmont, California, United States
ESADE BAN Barcelona, Catalonia, Spain
Gauss Ventures England, London, United Kingdom
Octave Ventures Canada, Ontario, Toronto
Onevest New York, New York, United States
PNF venture capital Luleå, Norrbottens Lan, Sweden
Spearflower VC -
Thakral Group Central Region, Singapore, Singapore

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rodin Therapeutics

Biotechnology
Health Care
Therapeutics
$27M18 Sep 2017 Cambridge, Massachusetts, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$50M18 Jul 2017 California, United States

Navitor Pharmaceuticals

Biopharma
Biotechnology
Developer Platform
Health Diagnostics
Pharmaceutical
$33M18 Dec 2015 Cambridge, Massachusetts, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$40M10 Nov 2015 Boulder, Colorado, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$45M01 Nov 2015 California, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$14M01 May 2015 California, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$8M18 Feb 2015 Boulder, Colorado, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$7M27 Jun 2014 Boulder, Colorado, United States

Bellicum Pharmaceuticals

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$14M07 Jan 2014 Houston, Texas, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Remeditex Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 17
Average round size 24M
Rounds per year 1.31
Peak activity year 2015
Lead investments 4
Follow on index 0.41
Exits 7
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rodin Therapeutics

Biotechnology
Health Care
Therapeutics
$27M18 Sep 2017 Cambridge, Massachusetts, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$50M18 Jul 2017 California, United States

Navitor Pharmaceuticals

Biopharma
Biotechnology
Developer Platform
Health Diagnostics
Pharmaceutical
$33M18 Dec 2015 Cambridge, Massachusetts, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$40M10 Nov 2015 Boulder, Colorado, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$45M01 Nov 2015 California, United States

VYNE Therapeutics

Health Care
Pharmaceutical
Therapeutics
$14M01 May 2015 California, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$8M18 Feb 2015 Boulder, Colorado, United States

Viridian Therapeutics

Biotechnology
Genetics
Health Care
Therapeutics
$7M27 Jun 2014 Boulder, Colorado, United States

Bellicum Pharmaceuticals

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$14M07 Jan 2014 Houston, Texas, United States
Crunchbase icon

Content report

The following text will be sent to our editors: